Akari Therapeutics PLC (AKTX)
1.26
-0.03
(-2.33%)
USD |
NASDAQ |
Jan 22, 16:00
1.29
+0.03
(+2.38%)
Pre-Market: 20:00
Akari Therapeutics Market Cap: 31.20M for Jan. 22, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| DBV Technologies SA | 97.25M |
| Ascendis Pharma AS | 7.525B |
| Cellectis SA | 153.14M |
| Adaptimmune Therapeutics PLC | 147.06M |
| Biodexa Pharmaceuticals PLC | 2.781M |
Market Cap Related Metrics
| Price | 1.26 |
| Earnings Yield | -218.4% |